Assay for cytokine panel 12 proto

General Details:

Name:
Assay for cytokine panel 12 proto
Steward:
PhenX
Definition:
This protocol provides instructions for drawing, processing, and storing blood according to the National Health and Nutrition Examination Survey (NHANES) and uses the multi-analyte fluorescent detection (MAFD) method to measure 12 different cytokines: Interferon gamma (IFN-gamma), Interleukin-1 beta (IL-1 beta), Interleukin-10 (IL-10), Interleukin-12 (IL-12), Interleukin-13 (IL-13), Interleukin-2 (IL-2), Interleukin-2 Receptor (IL-2R), Interleukin-4 (IL-4), Interleukin-5 (IL-5), Interleukin-6 (IL-6), Interleukin-8 (IL-8), Tumor Necrosis Factor alpha (TNF alpha). The Infectious Diseases and Immunity Working Group notes that although the recommendation is for the multi-analyte fluorescent detection (MAFD) method of Cytokine Panel 12 offered through ARUP Laboratories, there are additional cytokines or other immunoactive molecules that may be selected according to the individual condition(s) being studied.
Registration Status:
Qualified

Designations:

Designation:
Assay for cytokine panel 12 proto
Tags:
Short Name
Designation:
PhenX - assay for cytokine panel 12 protocol 160201
Tags:
Long Common Name

Designations:

Definition:
This protocol provides instructions for drawing, processing, and storing blood according to the National Health and Nutrition Examination Survey (NHANES) and uses the multi-analyte fluorescent detection (MAFD) method to measure 12 different cytokines: Interferon gamma (IFN-gamma), Interleukin-1 beta (IL-1 beta), Interleukin-10 (IL-10), Interleukin-12 (IL-12), Interleukin-13 (IL-13), Interleukin-2 (IL-2), Interleukin-2 Receptor (IL-2R), Interleukin-4 (IL-4), Interleukin-5 (IL-5), Interleukin-6 (IL-6), Interleukin-8 (IL-8), Tumor Necrosis Factor alpha (TNF alpha). The Infectious Diseases and Immunity Working Group notes that although the recommendation is for the multi-analyte fluorescent detection (MAFD) method of Cytokine Panel 12 offered through ARUP Laboratories, there are additional cytokines or other immunoactive molecules that may be selected according to the individual condition(s) being studied.
Tags:
Source: Regenstrief LOINC

Reference Documents:

ID:
Title:
URI:
Provider Org:
Language Code:
en-US
Document:
Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. Laboratory Procedures Manual. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2007.
ID:
Title:
URI:
Provider Org:
Language Code:
en-US
Document:
ARUP Laboratories, 500 Chipeta Way, Salt Lake City, UT 84108-1221, Phone: 800.242.2787, E-mail: clientservices@aruplab.com

Properties:

Key:
Related Names
Value:
PanPANEL.PHENXPanl
PnlPoint in timeRandom
Key:
Related Codes
Value:
Code SystemCodeCode TextCode Version
https://www.phenxtoolkit.org160201assay_for_cytokine_panel¿12
Key:
Fully-Specified Name
Value:
ComponentPropertyTimeSystemScaleMethod
PhenX - assay for cytokine panel 12 protocol 160201-Pt^Patient-PhenX
Key:
Basic Attributes
Value:
ClassTypeFirst ReleasedLast UpdatedChange ReasonPanel Type
PANEL.PHENXClinicalVersion 2.36Version 2.67Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Added the PhenX protocol ID to the Component to clearly define the protocol version for which this panel is based upon.Panel

Identifiers:

Source:
NLM
Id:
m1_aGa2ix
Version:
1.0
Source:
PhenX
Id:
160201
Version:
Source:
LOINC
Id:
62867-7
Version:
2.69